Nektar Therapeutics NKTR Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nektar Therapeutics's common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nektar Therapeutics's common stock, shares, outstanding?
- Nektar Therapeutics (NKTR) reported common stock, shares, outstanding of $20.38M in Q1 2026.
- How has Nektar Therapeutics's common stock, shares, outstanding changed year-over-year?
- Nektar Therapeutics's common stock, shares, outstanding decreased by 89.0% year-over-year, from $186.1M to $20.38M.
- What is the long-term trend for Nektar Therapeutics's common stock, shares, outstanding?
- Over 5 years (2020 to 2025), Nektar Therapeutics's common stock, shares, outstanding has grown at a -35.3% compound annual growth rate (CAGR), from $180.09M to $20.38M.